Search research articles
Contact Us
Filters
Showing results (661-670 of 962) with videos related to
Page
of 97
Sort By:
Journal of Cardiac Failure
|
March 2, 2026
Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients with Diabetes and Heart Failure: A SOLOIST-WHF Ancillary Study
Anis Ismail, Grace Erne, Alexi Vasbinder, et al.
European Heart Journal. Acute Cardiovascular Care
|
August 4, 2016
Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience
Sergio Leonardi, Renato D Lopes, Ph Gabriel Steg, et al.
American Heart Journal
|
September 25, 2004
Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI)
Carlo Di Mario, Leonardo Bolognese, Luc Maillard, et al.
Circulation. Heart Failure
|
May 1, 2023
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial
Karola S Jering, Brian L Claggett, Marc A Pfeffer, et al.
European Heart Journal
|
August 22, 2020
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial
José Tuñón, Philippe Gabriel Steg, Deepak L Bhatt, et al.
Cardiovascular Diabetology
|
October 17, 2020
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
Chao Gao, Mariusz Tomaniak, Kuniaki Takahashi, et al.
JAMA Cardiology
|
March 30, 2017
Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial
Patricia A Cowper, Shubin Sheng, Renato D Lopes, et al.
Stroke
|
November 20, 2010
Prevalence of coronary atherosclerosis in patients with cerebral infarction
Pierre Amarenco, Philippa C Lavallée, Julien Labreuche, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 17, 2021
External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial
Masafumi Ono, Hideyuki Kawashima, Hironori Hara, et al.
Journal of the American Heart Association
|
February 9, 2021
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
Giulia Magnani, Diego Ardissino, KyungAh Im, et al.
Page
of 97
Search research articles
Search
Showing results (661-670 of 962) with videos related to
Sort By:
Page
of 97
Journal of Cardiac Failure
|
March 2, 2026
Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients with Diabetes and Heart Failure: A SOLOIST-WHF Ancillary Study
Anis Ismail, Grace Erne, Alexi Vasbinder, et al.
European Heart Journal. Acute Cardiovascular Care
|
August 4, 2016
Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience
Sergio Leonardi, Renato D Lopes, Ph Gabriel Steg, et al.
American Heart Journal
|
September 25, 2004
Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI)
Carlo Di Mario, Leonardo Bolognese, Luc Maillard, et al.
Circulation. Heart Failure
|
May 1, 2023
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial
Karola S Jering, Brian L Claggett, Marc A Pfeffer, et al.
European Heart Journal
|
August 22, 2020
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial
José Tuñón, Philippe Gabriel Steg, Deepak L Bhatt, et al.
Cardiovascular Diabetology
|
October 17, 2020
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
Chao Gao, Mariusz Tomaniak, Kuniaki Takahashi, et al.
JAMA Cardiology
|
March 30, 2017
Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial
Patricia A Cowper, Shubin Sheng, Renato D Lopes, et al.
Stroke
|
November 20, 2010
Prevalence of coronary atherosclerosis in patients with cerebral infarction
Pierre Amarenco, Philippa C Lavallée, Julien Labreuche, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 17, 2021
External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial
Masafumi Ono, Hideyuki Kawashima, Hironori Hara, et al.
Journal of the American Heart Association
|
February 9, 2021
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
Giulia Magnani, Diego Ardissino, KyungAh Im, et al.
Page
of 97